Novartis Licenses Worldwide Rights To Paratek's Broad-Spectrum Antibiotic
Clarified regulatory path for antibiotics may have helped produce potentially lucrative deal for the private biotech.
Clarified regulatory path for antibiotics may have helped produce potentially lucrative deal for the private biotech.